Acute Porphyria Drug Database

G04BE08 - Tadalafil
Propably not porphyrinogenic
PNP

Rationale
Substrate for CYP 3A4. Does not give rise to CYP induction.
Chemical description
(To be edited, initial data ST OCT 04) Used (tablets 10-20 mg/dose) in erectile dysfunction. Selective inhibitor of cGMP- specific fhosphodiesterase, giving rise to relaxation of smooth muscle and increased blood flow into penis. Mainly metabolized by CYP 3A4.

Similar drugs
Explore alternative drugs in similar therapeutic classes G04B / G04BE or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙